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Background: Autonomic nervous function, as quantified by heart rate variability (HRV), has shown promise in predicting 
clinically important outcomes in the critical care setting; however, there is debate concerning its utility. HRV analysis was 
assessed as a practical tool for outcome prediction in two South African hospitals and compared with Acute Physiology and 
Chronic Health Evaluation II (APACHE II) scoring.
Method: In a dual centre, prospective, observational cohort study of patients admitted to the intensive care units (ICU) of two 
hospitals in KwaZulu-Natal, South Africa frequency domain HRV parameters were explored as predictors of: all-cause mortality at 
30 days after admission; ICU stay duration; the need for invasive ventilation; the need for inotrope/vasopressor therapy; and the 
need for renal replacement therapy. The predictive ability of HRV parameters against the APACHE II score for the study outcomes 
was also compared.
Results: A total of 55 patients were included in the study. Very low frequency power (VLF) was shown to predict 30-day mortality 
in ICU (odds ratio 0.6; 95% confidence interval 0.396–0.911). When compared with APACHE II, VLF remained a significant 
predictor of outcome, suggesting that it adds a unique component of prediction. No HRV parameters were predictive for the 
other secondary outcomes.
Conclusion: This study found that VLF independently predicted all-cause mortality at 30 days after ICU admission. VLF provided 
additional predictive ability above that of the APACHE II score. As suggested by this exploratory analysis larger multi-centre 
studies seem warranted.
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Introduction
Heart rate variability (HRV) is a tool used to assess central nervous 
system autonomic function and guidelines for its use have been 
in place for almost 20 years.1 HRV analysis has shown promise in 
predicting clinically relevant outcomes in the critical care setting, 
to risk stratify patients,2 and predict outcomes such as mortality3 
and multiple organ dysfunction syndrome (MODS).3,4 Enhanced 
outcome prediction may enable better resource allocation and 
potentially assist with end-of-life decisions. Our primary 
objective was to assess HRV analysis as a practical tool for 
outcome prediction and to compare it to Acute Physiology and 
Chronic Health Evaluation II (APACHE II) scoring. We complied 




We undertook a dual-centre, prospective, observational cohort 
study of patients admitted to the intensive care units (ICU) of two 
hospitals providing regional and tertiary level services in 
KwaZulu-Natal, South Africa. Ethical approval for the study was 
given through the University of KwaZulu-Natal Bio-ethics 
Committee (BE 414/14), and permission to conduct the study 
was given by the management of both hospitals and the national 
Department of Health.
Patients and setting
Our investigation was a sub-study of a multi-centre outcomes 
study that included both ICUs (30DOS: 30-day outcome study of 
patients in intensive care units in KwaZulu Natal [BE 210/14]). 
Consent to use patient data fell under this broader study. A 
convenience sampling method was used, which limited the total 
number of eligible patients to the time-frame of the parent 
study. Patients 18  years of age or older that were admitted to 
Edendale or Grey’s Hospital ICUs over a four-week period 
(October 20, 2014 to November 14, 2014) were considered 
eligible. This time period was selected to ensure a representative 
patient sample by avoiding school holidays and therefore a 
possible bias toward trauma patients. Eligible patients had a 
Holter taken within 24 hours of admission between 10h00 and 
13h00. The ethics committee waived the need for consent as 
Holter analysis is routine in these ICUs. Patients were excluded if 
they: were not admitted during the study time period; did not 
have a Holter of at least five minutes’ duration; were not in sinus 
rhythm; had artefacts or ectopic beats in more than 2% of their 
recording; or were lost to follow-up. Patients were followed up 
for 30  days after initial admission and those discharged from 
hospital were contacted telephonically.
HRV analysis
Holter recordings were done with Schiller Holters (MT-101) 
(Schiller AG, Baar, Switzerland) and analysed using Schiller MT-
200 software. Holters were CF classified (safe for direct cardiac 
application) and met the standards required for ECG recordings 
to be used in HRV analysis, as laid out by the Task Force of the 
European Society of Cardiology and the North American Society 
of Pacing and Electrophysiology.1 Initial Holter analysis was done 
manually to confirm sinus rhythm. The first five-minute segment 
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of the Holter recording was used for analysis, provided the 
segment met ECG criteria for inclusion. Five-minute recordings 
are recommended for short-term frequency domain analysis.1 
We excluded any patient who had a recording of less than five 
minutes, as VLF power measurements are less reliable in shorter 
recordings. Intervals between successive beats (RR intervals) 
were then exported to the HRV software analysis program, 
Kubios© version 2.2 (Department of Applied Physics, University 
of East Finland; available at http://kubios.uef.fi/). All Holter 
analyses were performed by the corresponding author.
The specific analysis of heart rate variability is complex. Broadly 
speaking, there are three categories of analysis: time-domain, 
frequency domain and non-linear. We used frequency domain 
analysis because it can be calculated from relatively shorter ECG 
recordings, which makes it more practical. Frequency domain 
methods employ power spectral density analysis, which assesses 
how variance is distributed as a function of frequency.1 This is 
further divided into parametric and non-parametric methods. 
We used a non-parametric method (fast Fourier transformation), 
which uses a simpler algorithm, has a higher processing speed 
and allows for easier post-processing of the spectrum.1 Practically 
these calculations are done through software packages, such as 
the Kubios© software we used in this study. There are several 
reviews available on this topic for interested readers.1,6,7
Outcomes
The primary outcome was the assessment of frequency-domain 
HRV parameters as a predictor of all-cause mortality at 30 days 
following ICU admission. Frequency domain analysis is one of 
the more commonly used techniques for analysis of HRV, using 
Fourier transformation to determine the amplitude or power of 
the contributing frequencies. Frequencies are classified into very 
low frequency (VLF: < 0.04 Hz), low frequency (LF: 0.04–0.15 Hz) 
and high frequency (HF: 0.15–0.4  Hz). Frequency-domain 
methods are preferred to time-domain methods when 
investigating short-term recordings.1 The parameters included 
for analysis were VLF power, LF power, HF power, total power, 
and the ratio of LF power to HF power (LF/HF ratio).
We assessed the same HRV parameters as predictors of the 
following secondary outcomes: ICU stay duration, need for 
invasive ventilation, inotrope/vasopressor therapy, and renal 
replacement therapy. We then compared the defined HRV 
parameters and the APACHE II score as predictors of all study 
outcomes. Invasive ventilation, inotrope/vasopressor therapy 
and RRT were defined as the need for the use of any of those 
modalities during the study period without consideration of 
their duration of use or dose.
Statistical analysis
The number of eligible patients admitted during the study 
period determined the sample size. Baseline characteristics of 
the included patients were reported as mean (standard deviation 
[SD]) for continuous variables and count (per cent) for categorical 
variables. To address the primary endpoint we first determined 
the proportion of patients who died at 30  days, together with 
their associated 95% confidence intervals. We then performed 
univariable logistic regression for each of the candidate predictor 
variables (VLF power, LF power, HF power, total power, and LF/HF 
ratio) to determine their association with the primary outcome. 
We log transformed variables not normally distributed before 
performing this analysis.
Predictors associated with the primary outcome (i.e. p < 0.1) 
were entered into a multivariable regression model. For all 
logistic regression analyses we used backward stepwise models. 
We assessed collinearity using the variance inflation factor (VIF), 
which measures the extent to which the variance of the model 
coefficients will be inflated (because of the correlation of the 
variable with other predictor variables) if that variable is included 
in the model. We considered variables with VIF > 10 co-linear and 
we excluded the variable with the lowest odds ratio (OR) on 
univariate analysis from the model.
For the study outcome of ICU stay we evaluated each of the 
variables identified as significantly predictive of the primary 
outcome in the preceding analysis, to determine their association 
with this secondary outcome. We then conducted linear 
regression to determine the strength of association. For the 
study outcomes of need for invasive ventilation, need for 
inotrope/vasopressor therapy, and need for renal replacement 
therapy we conducted logistic regression as detailed above to 
determine the strength of association between the HRV 
parameters and these outcomes.
We compared HRV variables identified as significantly predictive 
of the primary outcome with the APACHE II for the prediction of 
mortality at 30 days after ICU admission.
For all regression models, we reported the OR, corresponding 
standard error, 95% confidence intervals (CI) and associated p-
values. We reported p-values to 3 decimal places with p-values 
less than 0.001 reported as p < 0.001. For all tests, we used an 
alpha  =  0.05 level of significance. Examination of residuals 
provided an assessment of model assumptions for regression 
analyses. For the logistic regression model goodness-of-fit was 
performed using the appropriate Hosmer–Lemeshow tests. For 
the linear regression model performance was evaluated using 
adjusted R2 and ANOVA.
Results
As shown in Figure 1, 92 patients were admitted during the study 
period, of which 78 were eligible for inclusion on admission criteria. 
Seven patients were discharged without sufficient time for Holter 
analysis. One patient was excluded because he was in atrial 
fibrillation and four patients either did not receive Holter analysis or 
had a recording of insufficient length. Eleven patients were lost to 
follow-up and thus the primary outcome could not be determined.
Figure 1: Patient flow chart.
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Population characteristics
There were 55 patients included in the final analysis, 41 from 
Edendale Hospital ICU and 14 from Grey’s Hospital ICU: 22 female 
and 33 male. Average patient age was 42.3 years (range 20–84) 
with admissions from a variety of clinical disciplines: trauma 
(31%), internal medicine (24%), general surgery (22%), obstetrics 
(9%), urology (7%), orthopaedic surgery (5%) and gynaecology 
(2%). Thirty-five patients were admitted following surgery (64%). 
Eighteen of the 55 patients died within 30  days (33%). Thirty 
patients required invasive ventilation (55%), 19 required inotropic 
support (35%) and 2 needed renal replacement therapy (4%). The 
median duration of stay in ICU was 2.6 days (Range 1–22 days).
On univariate analysis, all candidate variables showed an association 
(p > 0.1) with the primary outcome (VLF p = 0.002, LF p = 0.058, HF 
p = 0.036, TP p = 0.002, LF/HF p = 0.046) and were thus entered into 
a multivariable regression model. This is shown in Table 1.
Following assessment for collinearity, HF and TP were excluded 
from further analysis (VIF > 10). VLF, LF and LF/HF were entered 
into the model for backward stepwise logistic regression and VLF 
was shown to be significant (p = 0.016); the quality of model fit 
was good. These findings showed that VLF predicted 30-day 
mortality in ICU (OR 0.6; 95% CI 0.396–0.911; p  =  0.016). HRV 
parameters were not predictive of any of the secondary outcomes, 
i.e. the need for ventilation, inotrope usage or duration of ICU stay. 
There were too few outcomes to perform analysis on RRT.
Having established VLF as the primary predictor of 30-day 
mortality, we compared VLF with APACHE II. Univariate analysis 
of APACHE II to 30-day mortality showed a strong association 
(p < 0.001). After log transformation the signal remained strong 
(p < 0.001). We then compared VLF and APACHE II. VLF remained 
predictive in the presence of the APACHE II score, suggesting 
that VLF provided addition predictive information above and 
beyond the APACHE II score.
Discussion
This study aimed to assess the utility of HRV parameters for the 
prediction of 30-day mortality after admission to ICU. We 
targeted frequency domain parameters as these are the 
recommended method for short-term analyses and this 
methodology has been used previously in similar clinical 
situations.3,8 We found VLF to be predictive of 30-day ICU 
mortality (OR 0.6; 95% CI 0.396–0.911; p  =  0.016). This finding 
confirmed the work by Schmidt et al.8 and Stein et al.9 showing 
that VLF predicts poor outcome in the ICU setting. Furthermore, 
when compared with APACHE II, VLF appeared to have 
independent predictive value, in keeping with Yien et al.10 HRV 
parameters were not independently predictive for any of the 
secondary outcomes (i.e. need for ventilation, inotropes or RRT, 
duration of ICU stay).
We focused on using HRV measures in a practical manner and in 
a real-world setting. Accordingly we used the lowest 
recommended duration for ECG recordings for the frequency 
domain analysis (> 5 minutes), and allowed for a three-hour 
period during which the ECG recording could be taken. Guidelines 
for the examination of VLF power reflect caution in using this 
measure in short-term recordings,1 possibly because the 
influences on VLF power (such as hormonal systems) exert their 
influence over a longer period. Previous studies reporting on VLF 
power used 25-minute10 and 24-hour recordings. It is significant 
that in our study VLF retained its predictive power even with 
short-term recordings used in a real-world environment. The 
autonomic contribution to frequency domain parameters is 
known to be different, with predominantly sympathetic influence 
over HF, and a balance of sympathetic and parasympathetic input 
into lower frequency variables.1 VLF is influenced by a large 
number of variables, including temperature, hormonal state and 
a strong parasympathetic influence.1,6,11 This may explain differing 
performances with respect to predictive ability over other 
frequency domain parameters in the intensive care setting.3
HRV is increasingly gaining popularity as a predictor of outcome 
in a variety of clinical environments, including trauma patients,12 
critically ill emergency department4 patients,13 septic patients on 
admission to ED,14 and the haemodynamically stable trauma 
patient.15 It has also been used to predict outcomes such as 
hypotension during obstetric spinal hypotension.16,17 Its use in 
ICU and anaesthesia has been extensively reviewed elsewhere.7 
There has been a significant amount of research into altered HRV 
in neonates with changes in HRV preceding clinical markers for 
the diagnosis of sepsis in neonates,18,19 as well as being predictive 
of mortality in this group of patients.20,21 In adult patients, altered 
HRV has also been shown to be an early marker of the onset of 
multiple organ dysfunction4 and has been shown to be predictive 
of outcome in head injury patients.22,23 It has been shown that 
HRV decreases with sedation24 and increases with sedation 
interruption.25 There is also evidence to suggest that depressed 
HRV is predictive of overall outcome in the critical care unit.26 Risk 
stratification in the ICU and the role of the various components 
of HRV analysis has also been further delineated in some detail.2 
A study by Yien et al., which looked specifically at HRV criteria to 
predict outcome in the ICU, showed that increases in the power 
density values of the LF and VLF components of HRV were related 
to improved outcome, while a decrease in these components 
was related to worse outcome.10 There was a positive correlation 
with APACHE II scores. The recordings in this study were taken 
from heart rate signals over 25 minutes and using an algorithm 
designed in the unit that was being studied.
In our study we found HRV to provide additional predictive 
information to the APACHE II scores. General illness severity 
scores are widely used in the ICU to assess resource use, predict 
Table 1: Univariable logistic regression analysis of log-transformed candidate variables
Results reported to three decimal places. (VLF: very low frequency; LF: low frequency; HF: high frequency; TP: total power; LF/HF: low frequency:high 
frequency ratio).
*p-value < 0.1 for entry into multivariable regression model.
Variable Odds ratio Standard error p-value Confidence interval
VLF 0.571 0.104 0.002* 0.399–0.816
LF 0.678 0.139 0.058* 0.453–1.014
HF 0.687 0.123 0.036* 0.483–0.976
TP 0.579 0.102 0.002* 0.409–0.818
LF/HF 0.691 0.128 0.046* 0.480–0.994
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outcome, and characterise disease severity and degree of organ 
dysfunction.26 APACHE is one of the generic scoring systems, 
which was revised to APACHE II in 1985 and is designed to predict 
outcome based on the severity of disease on admission.27 It is 
currently the world’s most widely used scoring system.26 APACHE 
II does not incorporate an HRV component; our study suggests 
that this could be a consideration.
There are a few limitations to our study. Our investigation 
occurred as a sub-study of a multi-centre observational outcomes 
study in ICUs, which limited the total number of patients we 
could recruit. Our results would have been more robust with a 
larger cohort. Eleven patients were also lost to follow-up in the 
parent study and were thus excluded. This affected the study size 
and introduced the possibility of bias, as these patients were 
likely to represent patients who survived to hospital discharge. 
We did not control for a variety of factors that may affect 
autonomic function, such as feeding status, degree of sedation, 
type of medication and underlying pathology, as we do not 
believe it feasible to control for these in a real -world setting. A 
detailed discussion on confounders and their effects in HRV 
studies in ICU has been published elsewhere.6,7 The use of 
APACHE II in a general ICU is also problematic because the 
original developmental data-set for APACHE II did not include 
trauma and obstetrics subsets. However, both ICUs in our study 
collect APACHE II scores as part of routine clinical governance 
and this information was also being collected as part of the 
30DOS study. Subset analysis was not performed as the small 
sample size would lead to an over-fitted model. Our results still 
reflect that HRV adds value to what remains the most widely 
used scoring system worldwide.
HRV appears to hold promise as a predictor of outcome, despite 
numerous challenges with HRV research in the ICU.28 Currently it is 
difficult to incorporate measurements into routine clinical care 
without modification and streamlining of the collection methods. 
Technically this should be easy to do by adding software to 
conventional monitors used in the ICU setting, the majority of 
which have an ECG sampling frequency sufficient to meet the 
standards set in guidelines for the use of HRV analysis.1 Current 
guidelines are now dated,1,28 and additional pragmatic research is 
required to further define which parameters are worth investigating. 
This study found that VLF independently predicted all-cause 
mortality at 30 days after ICU admission. VLF provided additional 
predictive ability above that of the APACHE II score. As suggested by 
this exploratory analysis larger multi-centre studies seem warranted.
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